)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Nakanishi
Nakanishi (7716) investor relations material
Nakanishi Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary7 Aug, 2026
Executive summary
Achieved double-digit sales growth across all business segments, with notable strength in Japan's Dental and Surgical businesses and all segments posting double-digit revenue growth.
Consolidated net sales rose 20.5% year-over-year to ¥47,234 million, supported by yen depreciation and M&A contributions from Acra Cut and Intech.
EBITDA increased 22.9% year-over-year to ¥12,769 million, with operating income up 32.0% to ¥10,012 million and net income attributable to owners of parent up 132.0% to ¥8,144 million.
Full-year financial forecast revised upward, with operating, ordinary, and net profit expected to reach record highs (excluding prior year one-off gains).
Enhanced shareholder returns with a higher share repurchase limit and a two-for-one stock split effective October 1, 2026.
Financial highlights
Q2 FY2026 net sales: ¥47,234M (+20.5% YoY); gross profit: ¥27,424M (+18.7% YoY); EBITDA: ¥12,769M (+22.9% YoY); operating profit: ¥10,012M (+32.0% YoY); net profit: ¥8,144M (+132.0% YoY); EPS: ¥98.07 (+67.1% YoY).
Forex impact added ¥2,884M to net sales YoY.
All segments posted double-digit sales growth: Dental (+14.6%), DCI (+23.6%), Surgical (+53.4%), Industrial (+28.6%).
Regional sales growth: Japan (+25.2%), North America (+25.7%), Europe (+23.2%), Asia (+9.8%), Others (+4.2%).
Total assets increased to ¥174,551M, and net assets to ¥122,009M as of June 30, 2026.
Outlook and guidance
FY2026 net sales forecast revised to ¥94,480M (+16.4% YoY); EBITDA ¥24,340M (+22.3% YoY); operating profit ¥16,215M (+15.0% YoY); net profit ¥13,544M (+21.0% YoY).
EPS forecast for FY2026 is ¥81.55 post-stock split (¥163.10 pre-split).
Assumed exchange rates: ¥155/USD, ¥180/EUR for 2H.
All business segments expected to continue growth, with Dental and DCI leading.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Nakanishi
- Sales expanded in FY2023, while FY2024 guidance points to lower operating income and net income.7716
Q4 2023 - Q1 2026 net income soared 803.9% on 21.3% sales growth, with all segments posting strong gains.7716Q1 2026
- Acquisition boosts U.S. market share and raises FY2026 sales and profit forecasts.7716Acquisition presentation
- Net sales up 5.4% YoY, but DCI impairment led to a net loss; record sales and profit forecast for FY2026.7716Q4 2025
- Net sales up 3.8% YoY, but EBITDA and net income declined; guidance unchanged.7716Q3 2025
- Surgical growth offset flat sales, but net income dropped 50% amid currency headwinds.7716Q2 2025
- Sales surged 37.4% but net profit dropped 63.7%; outlook and dividend steady.7716Q3 2024
- Sales surged 36.4% year-over-year, but net income declined 11.9% amid mixed segment results.7716Q2 2024
- Sales rose, but profits plunged on forex and tax hits; outlook lowered amid global risks.7716Q1 2025
Next Nakanishi earnings date
Q3 202613 Nov, 2026
Nakanishi
Next Nakanishi earnings date
Q3 202613 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Nakanishi Inc. is a Japanese company specializing in the design, manufacture, and distribution of high-precision rotary cutting tools and equipment, primarily for dental and industrial applications. The company produces a wide range of dental handpieces, surgical instruments, and related accessories, catering to dental professionals and healthcare institutions. In the industrial sector, Nakanishi offers electric and pneumatic tools used in high-precision machining processes, meeting the needs of manufacturing and engineering industries globally. The company is headquartered in Kanuma, Japan, and its shares are listed on the TSE.